BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2122578)

  • 1. Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumours of bone.
    Ueda Y; Oda Y; Tsuchiya H; Tomita K; Nakanishi I
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(4):291-7. PubMed ID: 2122578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of collagenous proteins in cartilaginous tumors: characteristic distribution of type IX collagen.
    Kawashima A; Ueda Y; Tsuchiya H; Tomita K; Nagai Y; Nakanishi I
    J Cancer Res Clin Oncol; 1993; 120(1-2):35-40. PubMed ID: 8270606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study on collagenous proteins and biophysical analysis of crystals in extraskeletal chondroma.
    Ota M; Oda Y; Nakanishi I
    Pathol Int; 1995 Aug; 45(8):596-601. PubMed ID: 7496505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
    Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
    Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
    Rozeman LB; Hameetman L; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
    J Pathol; 2005 Mar; 205(4):476-82. PubMed ID: 15685701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Matrix gene expression pattern as indicators of the biology of cartilage-forming tumors].
    Aigner T; Unni CC; Bjornsson J; Kirchner T
    Verh Dtsch Ges Pathol; 1998; 82():178-83. PubMed ID: 10095430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
    J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
    Kawashima A; Okada Y; Nakanishi I; Ueda Y; Iwata K; Roessner A
    Gen Diagn Pathol; 1997 Feb; 142(3-4):129-37. PubMed ID: 9065576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
    Lee FY; Yu J; Chang SS; Fawwaz R; Parisien MV
    J Bone Joint Surg Am; 2004 Dec; 86(12):2677-85. PubMed ID: 15590853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression and DNA ploidy of cartilage lesions.
    Coughlan B; Feliz A; Ishida T; Czerniak B; Dorfman HD
    Hum Pathol; 1995 Jun; 26(6):620-4. PubMed ID: 7774891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of angiogenic factors and cyclooxygenase-2 expression in cartilaginous tumors- clinical and histological correlation.
    Cintra FF; Etchebehere M; Gonçalves JC; Cassone AE; Amstalden EM
    Clinics (Sao Paulo); 2011; 66(9):1591-6. PubMed ID: 22179165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase digestion of aggrecan in human cartilage tumours.
    Toriyama M; Rosenberg AE; Mankin HJ; Fondren T; Treadwell BV; Towle CA
    Eur J Cancer; 1998 Nov; 34(12):1969-73. PubMed ID: 10023324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas.
    Dornauer K; Söder S; Inwards CY; Bovee JV; Aigner T
    Pathol Int; 2010 May; 60(5):365-72. PubMed ID: 20518886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and biochemical studies on the collagenous proteins of human osteosarcomas.
    Ueda Y; Nakanishi I
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 58(1):79-88. PubMed ID: 2574516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular variant of extraskeletal myxoid chondrosarcoma of abdominal wall--a case report with comparative immunohistochemical study on cartilaginous collagenous proteins in various myxoid mesenchymal tumors.
    Ueda Y; Okada Y; Nakanishi I
    J Cancer Res Clin Oncol; 1992; 118(2):147-51. PubMed ID: 1531226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
    Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
    Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
    Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
    J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of collagenous components in healthy periodontal tissues of the rat and marmoset (Callithrix jacchus). II. Distribution of collagen types IV, V and VI.
    Romanos GE; Schröter-Kermani C; Hinz N; Wachtel HC; Bernimoulin JP
    J Periodontal Res; 1991 Jul; 26(4):323-32. PubMed ID: 1714953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroblastoma of bone. A clinical, radiological, light and immunohistochemical study.
    Edel G; Ueda Y; Nakanishi J; Brinker KH; Roessner A; Blasius S; Vestring T; Müller-Miny H; Erlemann R; Wuisman P
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(4):355-66. PubMed ID: 1384228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunofluorescence localization of prolyl 4-hydroxylase isoenzymes and type I and II collagens in bone tumours: type I enzyme predominates in osteosarcomas and chondrosarcomas, whereas type II enzyme predominates in their benign counterparts.
    Nissi R; Böhling T; Autio-Harmainen H
    Acta Histochem; 2004; 106(2):111-21. PubMed ID: 15147632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.